(2R)-N-[4-[(3R)-3-ethyl-2,6-dioxopiperidin-3-yl]phenyl]-2-fluoro-2-(4-methoxyphenyl)acetamide | 1205648-10-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (2R)-N-[4-[(3R)-3-ethyl-2,6-dioxopiperidin-3-yl]phenyl]-2-fluoro-2-(4-methoxyphenyl)acetamide
• CAS: 1205648-10-7
• 化学式: C₂₂H₂₃FN₂O₄
• 分子量: 398.434
• InChiKey: DPPZXNZKDWEXID-DENIHFKCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  84.5
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  (R)-(+)-氨鲁米特 、 4-甲氧基苯乙酰氯 在 bis-triphenylphosphine-palladium(II) chloride 、 benzoylquinidine 、 N-氟代双苯磺酰胺 、 N,N-二异丙基乙胺 、 4-二甲氨基吡啶 作用下， 以 四氢呋喃 为溶剂， 反应 8.0h， 以98%的产率得到(2R)-N-[4-[(3R)-3-ethyl-2,6-dioxopiperidin-3-yl]phenyl]-2-fluoro-2-(4-methoxyphenyl)acetamide
  参考文献：
  名称：

  Combining Asymmetric Catalysis with Natural Product Functionalization through Enantioselective α-Fluorination

  摘要：

  An examination into the derivatization of various natural products using newly developed alpha-fluorination methodology is disclosed. An activated ketene enolate, generated from in acid chloride, is allowed to react with an electrophilic fluorine source (NFSi). Quenching the reaction with a nucleophilic natural product produces biologically relevant alpha-fluorinated carbonyl derivatives of select chemotherapeutics, antibiotics, and other pharmaceuticals.

  DOI：

  10.1021/jo9024072

文献信息

• Combining Asymmetric Catalysis with Natural Product Functionalization through Enantioselective α-Fluorination
  作者：Jeremy Erb、Ethan Alden-Danforth、Nathan Kopf、Michael T. Scerba、Thomas Lectka

  DOI：10.1021/jo9024072

  日期：2010.2.5

  An examination into the derivatization of various natural products using newly developed alpha-fluorination methodology is disclosed. An activated ketene enolate, generated from in acid chloride, is allowed to react with an electrophilic fluorine source (NFSi). Quenching the reaction with a nucleophilic natural product produces biologically relevant alpha-fluorinated carbonyl derivatives of select chemotherapeutics, antibiotics, and other pharmaceuticals.